Latest Articles

  • Overcoming obesity: Weight-loss drugs are underused
    Amjad Kanj, MD, MPH and Diane Levine, MD, FACP
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 602-604; DOI: https://doi.org/10.3949/ccjm.87a.19102

    Successful management of obesity requires a multifaceted approach.

  • In Reply: Trousseau sign and syndrome: Erroneous terms
    Satish S. Maharaj, MD, Michael Omar, MBBS, Karan Seegobin, MBBS and Simone Chang, MBBS
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 586; DOI: https://doi.org/10.3949/ccjm.87c.10003

    Trousseau sign should continue to be taught and recognized on physical examination.

  • Miliary tuberculosis in a patient with end-stage liver disease
    Victoria Poplin, MD, Brent Harbaugh, DO, MA, Matthias Salathe, MD and Nathan C. Bahr, MD, MA
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 590-593; DOI: https://doi.org/10.3949/ccjm.87a.19143

    Chest radiography showed patchy left basilar consolidation with subtle, diffuse interstitial opacities.

  • Promoting resiliency in adolescents during a pandemic: A guide for clinicians and parents
    Ellen S. Rome, MD, MPH, Perry B. Dinardo, MA and Veronica E. Issac, MD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 613-618; DOI: https://doi.org/10.3949/ccjm.87a.20055

    Parents of adolescents may face unique challenges in helping their children navigate changes to their daily routine.

  • COVID-19 and the kidney
    COVID-19 and the kidney
    Mohamed Hassanein, MD, Yeshwanter Radhakrishnan, MD, John Sedor, MD, Tushar Vachharajani, MD, Vidula T. Vachharajani, MD, Joshua Augustine, MD, Sevag Demirjian, MD and George Thomas, MD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 619-631; DOI: https://doi.org/10.3949/ccjm.87a.20072

    The kidney may be a target of SARS-CoV-2 infection.

  • A sneaky vascular disease
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 581-582; DOI: https://doi.org/10.3949/ccjm.87b.10020

    Cholesterol embolization syndrome may provide insights into atherosclerotic disease.

  • When is contrast needed for abdominal and pelvic CT?
    Mark Radetic, MD, Robert DeVita, MD and John Haaga, MD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 595-598; DOI: https://doi.org/10.3949/ccjm.87a.19093

    The decision to use contrast depends on the diagnosis suspected.

  • Trousseau sign and syndrome: Erroneous terms
    Steven Yale, MD, MACP, Halil Tekiner, PhD, Joseph Mazza, MD and Eileen Scott Yale, MD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 585; DOI: https://doi.org/10.3949/ccjm.87c.10002

    Trousseau never described a constellation of symptoms in this disease.

  • Should we give triple therapy to patients with atrial fibrillation after percutaneous intervention?
    Asim Kichloo, MD, Michael M. Aljadah, MD, Farah Wani, MD and Sindhura Ananthaneni, MD
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 599-601; DOI: https://doi.org/10.3949/ccjm.87a.19115

    Triple therapy is aggressive and carries high risks of bleeding and death.

  • The pulmonary pathology of COVID-19
    Andrea Valeria Arrossi, MD and Carol Farver, MD
    Cleveland Clinic Journal of Medicine September 2020, DOI: https://doi.org/10.3949/ccjm.87a.ccc063

Pages